🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Here's our The Lancet Oncology Policy Review! Please RT🙏 Defining the roadmap to a UK national #lungcancer #screening programme #TLHC authors.elsevier.com/a/1h0Qb5EIIgLp… Such a fab community. Dedicated, wise, friendly. Pleasure to write with. Bring on full roll-out! BTOG Roy Castle Lung Cancer Foundation

1/15 🧵 I'm thrilled to share the fantastic news that our Pan-Cancer T cell Atlas is now live Nature Medicine nature.com/articles/s4159… MD Anderson Cancer Center #SingleCell #SpatialOmics #TumorMicroenvironment #CancerImmunotherapy

By👩‍🔬: Y. Chu, E. Dai, Y. Li, Guangchun Han, G. Pei, D. R. Ingram,... Charles Swanton, X.-D. Cheng, Hussein Abbas, M. Gillison, K. Bhat, AlexanderLazarMDPhD, Michael Green, PhD, Kevin Litchfield, Humam Kadara, @tcellsrus, Linghua Wang, MD, PhD. Nature Medicine MD Anderson Cancer Center nature.com/articles/s4159…

Read the paper featured on the cover— Late-stage #melanoma: A diversity of evolutionary pathways, by Lavinia Spain, Alexander Coulton, Irene, Andrew Rowan, Desiree Schnidrig Kevin Litchfield, Charles Swanton, @MariamJHanjani, @TurajlicLab et al. bit.ly/43pJhdZ The Francis Crick Institute

Immunotherapy: Purpose, Resistance, and Toxicity— Toni K. Choueiri, Valentina Hoyos Velez, Sherene Loi, and Kevin Litchfield will address this topic in a State-of-the-Art session at #SABCS23. Learn more: bit.ly/3DMxlYt Toni Choueiri, MD Valentina Hoyos Velez, MD Sherene Loi, MD Kevin Litchfield

We’ll be at #ELRIGDD23 at Booth F10 on 18 October! Don't miss Kevin Litchfield’s (@UCL) talk on immuno-oncology therapeutic discovery at 15.45 🧑‍🔬 We look forward to seeing you there - visit us to find out about our #DrugDiscovery research. Register here: elrig.eventsair.com/dd23/

We've got a full house at Kevin Litchfield's talk in Auditorium 2! For more insights from Kevin, catch him at our panel discussion today at 16:30.

Stimulating talk by Kevin Litchfield UCL Cancer Institute on using the results from TRACERx lung to inform the development of a preventative cancer vaccine in non-small cell lung cancer #OxPPSymp23

Meet our #MakingDataFAIR webinar speakers below 👇 Learn how to apply FAIR principles to your research from academic + commercial perspective at 1-2pm next Monday: bit.ly/3Qi8bHg Kevin Litchfield | The Francis Crick Institute | Cancer Research Horizons | @katemurat | ELIXIR UK #CRUKDataSeries

We are happy to share our latest review and views on the key role that FcRs play impacting the in vivo activity of immune modulatory antibodies in cancer. Full text rdcu.be/ds0Vz Well done Quezada Lab Kevin Litchfield teams! nature.com/articles/s4156…

(Part of) the Centre for cancer genomics and computational biology Barts Cancer Institute (Queen Mary) attending one of Bart’s iconic Christmas parties! Happy holiday season from us! 🎉🎈🍾

We are recruiting a Research Scientist in Computational Biology Isomorphic Labs - building on the latest AI models #AlphaFold and beyond to redefine drug discovery. A hugely exciting time! boards.greenhouse.io/isomorphiclabs…

New week, new opening! We are looking for machine learning scientists to create the next generation state-of-the-art models for computational biology. There's so much tantalizing potential, exemplified by incredible recent works like Enformer, Evo, AlphaMissense, to create a

We're excited to announce #AlphaFold 3 with Google DeepMind in nature: our new AI model for predicting biomolecule structures with unprecedented breadth and accuracy. Expanding beyond proteins to tackle DNA, RNA, small molecules to fuel advances in biology & drug design 🧵

Together with Charles Swanton, delighted to share that our new tool, MHC Hammer - which can detect different types of HLA disruption - mutation, loss, RNA repression and alt. splicing - is now out in #NatureGenetics and available to use…nature.com/articles/s4158…... 🧵below

We are thrilled to share the breaking news that our CEO and founder Demis Hassabis and Google DeepMind colleague John Jumper have been awarded the 2024 Nobel Prize in Chemistry for their groundbreaking work creating AlphaFold alongside David Baker for computational protein

Congratulations Evie Fitzsimons and Danwen Qian on an amazing paper!

Excited to share that the AlphaFold 3 model code and weights are now available for academic use. Looking forward to seeing what new research this unlocks and how the research community builds on AlphaFold 3 for scientific discoveries github.com/google-deepmin… 1/2

Check this out if you're in Vancouver!

We are pleased to announce our participation in the UK Biobank Pharma Proteomics Project; bringing together a consortium of 14 biopharma companies supporting the UK Biobank in the world’s most comprehensive protein study. This new study aims to increase a unique proteomics